CheckMan Stock Market Overview

Perspective Therapeutics, Inc. retains a Strong Buy rating, driven by promising VMT-a-NET data and Sanofi deprioritizing a competing SSTR2-targeted therapy. CATX's VMT-a-NET achieved 76% progression-free and alive status in SSTR2 NET patients, with pivotal mid-2026 data readouts expected to drive further value. Upcoming catalysts include full 48-week cohort 2 data, higher-dose cohort 3 results, and additional pipeline readouts for VMT01 and PSV359 in 2026.

RCI Q4 revenues jump 13% year over year, driven by a surge in Media growth and higher adjusted EBITDA.

Were you affected by investment losses in BBWI securities between June 4, 2024, and November 19, 2025? Affected Investor Losses Summary Bath & Body Works, Inc. securities fraud class action filed Purchasers or acquirers of Bath & Body Works, Inc. (NYSE: BBWI) securities Seeking recovery of investment losses for material misstatements and/or omissions (as alleged) from June 4, 2024 through November 19, 2025 Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) can assist at no cost to investor RADNOR, Pa.

Dr. Michael Burry, the man made famous from The Big Short, has had a lot of things to say in recent months.

Covenant Logistics Group, Inc. (CVLG) Q4 2025 Earnings Call Transcript

SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The latest adverse development for Corcept Therapeutics (NASDAQ: CORT) concerning its proposed treatment of patients with hypercortisolism (also known as Cushing's syndrome) – relacorilant – came on January 30, 2026 when Reuters reported that the FDA “warned the company ‘on several occasions' not to submit its drug application.” This news sent the price of Corcept shares tumbling $7.81 (-17%) during trading that day.

Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

LOS ANGELES, Jan. 30, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS) have opportunity to lead the securities fraud class action lawsuit.

Economic activity is solid, consumption is high, and that means lots of garbage, which is a profitable business and an industry expected to continue growing.

Verizon (NYSE: VZ) has been a “disappointment” for investors in recent years. After flirting with $60 during the COVID pandemic, it bottomed out near $30 in late 2023 and is trading at about $44 currently.